You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: February 29, 2024

METADATE CD Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Metadate Cd patents expire, and when can generic versions of Metadate Cd launch?

Metadate Cd is a drug marketed by Aytu Biopharma and is included in one NDA.

The generic ingredient in METADATE CD is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.

Drug patent expirations by year for METADATE CD
Drug Prices for METADATE CD

See drug prices for METADATE CD

Drug Sales Revenue Trends for METADATE CD

See drug sales revenues for METADATE CD

Recent Clinical Trials for METADATE CD

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Matthew O'BrienPhase 4
Matthew J O'Brien, PhD, BCBA-DPhase 4
Craig RushEarly Phase 1

See all METADATE CD clinical trials

Pharmacology for METADATE CD
Paragraph IV (Patent) Challenges for METADATE CD
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
METADATE CD Extended-release Capsules methylphenidate hydrochloride 40 mg 021259 1 2007-03-15
METADATE CD Extended-release Capsules methylphenidate hydrochloride 10 mg, 20 mg and 30 mg 021259 1 2005-05-13

US Patents and Regulatory Information for METADATE CD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aytu Biopharma METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-003 May 27, 2003 AB2 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aytu Biopharma METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-004 Feb 19, 2006 AB2 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aytu Biopharma METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-001 Apr 3, 2001 AB2 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aytu Biopharma METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-002 Jun 19, 2003 AB2 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aytu Biopharma METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-006 Feb 19, 2006 AB2 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aytu Biopharma METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-005 Feb 19, 2006 AB2 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for METADATE CD

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aytu Biopharma METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-003 May 27, 2003 ⤷  Try a Trial ⤷  Try a Trial
Aytu Biopharma METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-004 Feb 19, 2006 ⤷  Try a Trial ⤷  Try a Trial
Aytu Biopharma METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-001 Apr 3, 2001 ⤷  Try a Trial ⤷  Try a Trial
Aytu Biopharma METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-002 Jun 19, 2003 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for METADATE CD

See the table below for patents covering METADATE CD around the world.

Country Patent Number Title Estimated Expiration
Hungary 0303695 ⤷  Try a Trial
Spain 2618603 ⤷  Try a Trial
Portugal 2103307 ⤷  Try a Trial
Denmark 2103307 ⤷  Try a Trial
Canada 2426883 FORMULATIONS A LIBERATION MODIFIEE PAR METHYLPHENIDATE (METHYLPHENIDATE MODIFIED RELEASE FORMULATIONS) ⤷  Try a Trial
European Patent Office 2103307 Formulations de libération modifiée de méthylphénidate (Methylphenidate modified release formulations) ⤷  Try a Trial
Australia 9701101 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.